BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30482931)

  • 21. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 5. Diagnostic accuracy studies.
    Manchikanti L; Derby R; Wolfer L; Singh V; Datta S; Hirsch JA
    Pain Physician; 2009; 12(3):517-40. PubMed ID: 19461821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for the use of omics-based predictors in clinical trials.
    McShane LM; Cavenagh MM; Lively TG; Eberhard DA; Bigbee WL; Williams PM; Mesirov JP; Polley MY; Kim KY; Tricoli JV; Taylor JM; Shuman DJ; Simon RM; Doroshow JH; Conley BA
    Nature; 2013 Oct; 502(7471):317-20. PubMed ID: 24132288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders.
    Lenze EJ; Nicol GE; Barbour DL; Kannampallil T; Wong AWK; Piccirillo J; Drysdale AT; Sylvester CM; Haddad R; Miller JP; Low CA; Lenze SN; Freedland KE; Rodebaugh TL
    J Psychiatry Neurosci; 2021 Jan; 46(1):E97-E110. PubMed ID: 33206039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpreting patient treatment response in analgesic clinical trials: implications for genotyping, phenotyping, and personalized pain treatment.
    Dworkin RH; McDermott MP; Farrar JT; O'Connor AB; Senn S
    Pain; 2014 Mar; 155(3):457-460. PubMed ID: 24071599
    [No Abstract]   [Full Text] [Related]  

  • 25. Make journals report clinical trials properly.
    Goldacre B
    Nature; 2016 Feb; 530(7588):7. PubMed ID: 26842021
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Assessing and enhancing clinical significance/social validity of intervention research in pediatric psychology.
    Rapoff MA
    J Pediatr Psychol; 2010 Mar; 35(2):114-9. PubMed ID: 19914955
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach.
    Seegmiller AC; Kim AS; Mosse CA; Levy MA; Thompson MA; Kressin MK; Jagasia MH; Strickland SA; Reddy NM; Marx ER; Sinkfield KJ; Pollard HN; Plummer WD; Dupont WD; Shultz EK; Dittus RS; Stead WW; Santoro SA; Zutter MM
    Am J Clin Pathol; 2013 Nov; 140(5):643-50. PubMed ID: 24124142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer trial errors revealed.
    Samuel Reich E
    Nature; 2011 Jan; 469(7329):139-40. PubMed ID: 21228842
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging standards in statistical practice: implications for clinical trials in rehabilitation medicine.
    Millis SR
    Am J Phys Med Rehabil; 2003 Oct; 82(10 Suppl):S32-7. PubMed ID: 14502037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten ways to improve the use of statistical mediation analysis in the practice of child and adolescent treatment research.
    Maric M; Wiers RW; Prins PJ
    Clin Child Fam Psychol Rev; 2012 Sep; 15(3):177-91. PubMed ID: 22418896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
    Li M; Yu T; Hu YF
    Stat Med; 2015 Jun; 34(14):2222-34. PubMed ID: 25779099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prioritizing personalized medicine.
    Shomron N
    Genet Res (Camb); 2014 Jul; 96():e007. PubMed ID: 25579247
    [No Abstract]   [Full Text] [Related]  

  • 33. Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodology.
    Leon AC
    J Clin Psychiatry; 2001; 62 Suppl 4():12-6; discussion 37-40. PubMed ID: 11229782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
    Verschraegen CF; Rehman H; Pulluri B; DeKay J; Barry M; Folefac E; Dittus K; Holmes C; Sprague J; Ades S; Gibson PC
    Oncology; 2017; 92(1):55-60. PubMed ID: 27820931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethics and statistical methodology in clinical trials.
    Palmer CR
    J Med Ethics; 1993 Dec; 19(4):219-22. PubMed ID: 8308877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker imprecision in precision medicine.
    Pritzker K
    Expert Rev Mol Diagn; 2018 Aug; 18(8):685-687. PubMed ID: 29939098
    [No Abstract]   [Full Text] [Related]  

  • 37. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent development on statistical methods for personalized medicine discovery.
    Zhao Y; Zeng D
    Front Med; 2013 Mar; 7(1):102-10. PubMed ID: 23377890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic Alteration-Driven Clinical Trial Designs in Oncology.
    Simon R
    Ann Intern Med; 2016 Aug; 165(4):270-8. PubMed ID: 27214515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards precision medicine for sepsis patients.
    Pickkers P; Kox M
    Crit Care; 2017 Jan; 21(1):11. PubMed ID: 28077168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.